Heart Transplant and Pregnancy
There was no difference in graft loss from delivery in HTRs who developed preeclampsia during pregnancy. Regardless of preeclampsia, pregnant HTRs are more likely than the general population to experience severe maternal morbidity. These findings provide pertinent information for counseling heart transplant recipients who pursue pregnancy.
Authors
- Ophelia Yin (ORCID: https://orcid.org/0000-0002-1933-2262)
- Vanessa Kirschner
- Yalda Afshar (ORCID: https://orcid.org/0000-0003-3807-7022)
- Lisa Coscia (ORCID: https://orcid.org/0000-0003-2842-9661)
- Negeen Shahandeh (ORCID: https://orcid.org/0000-0002-7811-8063)
- S. Constantinescu
- Roxanna A. Irani (ORCID: https://orcid.org/0000-0003-3752-4433)
- Prisca C. Diala
- Michael J. Moritz (ORCID: https://orcid.org/0000-0002-6482-3546)
Institutions
- University of California, Los Angeles (US)
- Reproductive Science Center (US)
- Gift of Life Michigan (US)
- Advanced Dermatology (US)
- Temple University (US)
Publication Details
- Journal
- JACC Heart Failure
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1016/j.jchf.2024.11.016
- Citations
- 3
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 5.64